Description
Cagrilintide Dosage & Use
Cagrilintide is a cutting-edge long-acting amylin analogue developed by Novo Nordisk. This dual amylin and calcitonin receptor agonist offers a novel mechanism of action for weight management, providing researchers with a potent tool for metabolic health studies.
🚀 Key Benefits
- *Dual Receptor Activation: Simultaneously targets amylin and calcitonin receptors to regulate appetite, enhance satiety, and modulate glucose metabolism.
- *Clinically Proven Efficacy: Clinical studies have demonstrated that Cagrilintide leads to clinically significant, dose-dependent weight loss, with greater reductions observed at higher doses, similar to retatrutide.
- *Enhanced Metabolic Health: Treatment with Cagrilintide has been associated with significant reductions in body weight and improved metabolic parameters.
- *Cost-Effective Research Tool: The 5mg vial offers a more affordable option for extended research protocols, reducing the cost per milligram compared to higher doss.
🧪 Composition
- *Active Ingredient: Cagrilintide
- *Concentration: 5mg per vial.
- *Form: Lyophilized peptide powder.
📦 Usage & Storage
- Intended Use: For research purposes only
- Storage: Store lyophilized powder in a cool, dry place. After reconstitution, refrigerate at 2–8°C and use within the designated study period.
Reviews
There are no reviews yet.